Michael Scolaro

Michael Scolaro

Oct 08, 2017

Group 6 Copy 167
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are climate change and air pollution triggering cardiovascular disease?

Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

Can blood lactate levels help guide treatment for birds suffering from monofilament line entanglement injuries?

Fishing line entanglement injuries are a common problem affecting over 200 different wildlife species globally...

Open Insulin

A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

Backer Badge Funded